Question One
The increase incidence of deaths from defective and contaminated products leaves the average consumer at a disadvantage (Kufman, 2008; Woodcock, 2008 and WJLA, 2014). The consumers purchase the products unaware of the fact that they might be contaminated. Since the implicated products are produced in known countries, regulatory authorities should require the labeling of the products to include information on the country of production. Additionally, the outsourcing of the production of products for medical use should be done in countries where there are strict regulations on quality.
Question Two
Despite the presence of goo clinical practices, there is a feeling that ...